MARKET

IIN

IIN

IntriCon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.74
+0.02
+0.10%
After Hours: 20.74 0 0.00% 16:00 09/23 EDT
OPEN
20.79
PREV CLOSE
20.72
HIGH
20.80
LOW
20.42
VOLUME
5.52K
TURNOVER
--
52 WEEK HIGH
28.16
52 WEEK LOW
11.44
MARKET CAP
188.68M
P/E (TTM)
152.61
1D
5D
1M
3M
1Y
5Y
VPG vs. IIN: Which Stock Should Value Investors Buy Now?
Zacks.com · 6d ago
Should You Think About Buying IntriCon Corporation (NASDAQ:IIN) Now?
IntriCon Corporation ( NASDAQ:IIN ), is not the largest company out there, but it received a lot of attention from a...
Simply Wall St. · 08/31 12:15
Intricon Raises FY21 Sales Guidance From $119M-$123M To $121M-$125M vs $121.02M Est.
Guidance Intricon now expects 2021 revenue to range between $121 million to $125 million, representing year-over-year growth of 18-22%. This compares to the previous range of $119 million to $123 million, or 16-20%
Benzinga · 08/09 21:19
IntriCon Q2 EPS $(0.13) Misses $0.08 Estimate, Sales $30.20M Beat $28.56M Estimate
IntriCon (NASDAQ:IIN) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $0.08 by 262.5 percent. This is a 550 percent decrease over losses of $(0.02) per share from the same
Benzinga · 08/09 21:18
-- Earnings Flash (IIN) INTRICON CORPORATION Reports Q2 EPS $0.23, vs. Street Est of $0.08
MT Newswires · 08/09 16:14
Intricon Hires David Liebl as Vice President of R&D
ARDEN HILLS, Minn., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, and manufacturing miniature interventional, implantable and body-worn medical devices, today a...
GlobeNewswire · 08/09 12:00
Intricon to Announce 2021 Second Quarter Results on Monday, August 9, 2021
Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2021 second quarter r...
GlobeNewswire · 07/26 20:05
Could The IntriCon Corporation (NASDAQ:IIN) Ownership Structure Tell Us Something Useful?
A look at the shareholders of IntriCon Corporation ( NASDAQ:IIN ) can tell us which group is most powerful...
Simply Wall St. · 07/25 09:31
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IIN. Analyze the recent business situations of IntriCon through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IIN stock price target is 28.50 with a high estimate of 30.00 and a low estimate of 27.00.
EPS
Institutional Holdings
Institutions: 113
Institutional Holdings: 8.72M
% Owned: 95.83%
Shares Outstanding: 9.10M
TypeInstitutionsShares
Increased
15
366.77K
New
16
657.75K
Decreased
32
1.16M
Sold Out
13
190.29K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.88%
Healthcare Equipment & Supplies
+0.77%
Key Executives
Non-Executive Chairman/Independent Director
Philip Smith
President/Chief Executive Officer/Director
Scott Longval
Chief Financial Officer
Ellen Scipta
Senior Vice President/Director of Sales/Director of Marketing
Michael Geraci
Senior Vice President
Dennis Gonsior
Vice President - Research & Development
David Liebl
Director
Mark Gorder
Independent Director
Nicholas Giordano
Independent Director
Raymond Huggenberger
Independent Director
Robert Masucci
Independent Director
Kathleen Pepski
Independent Director
Heather Rider
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.045
09/12/2001
--
Dividend USD 0.045
06/13/2001
--
Dividend USD 0.045
03/13/2001
--
Dividend USD 0.045
12/13/2000
--
Dividend USD 0.045
09/13/2000
01/01/1999
Dividend USD 0.045
06/13/2000
01/01/1999
Dividend USD 0.045
03/13/2000
01/01/1999
Dividend USD 0.045
12/13/1999
  • All
  • Financials
  • Insiders
More
About IIN
Intricon Corporation is a joint development manufacturer (JDM) of micromedical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micromedical products for markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. The Company manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and body-worn devices for medical device manufacturers. It offers medical device manufacturers the capabilities to design, develop, manufacture, package and distribute medical devices. The Company has facilities in facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.

Webull offers kinds of IntriCon Corporation stock information, including NASDAQ:IIN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IIN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IIN stock methods without spending real money on the virtual paper trading platform.